Skip to main content

Advertisement

Log in

Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objective

Diabetes mellitus (DM) had been discovered as an independent risk factor for high on-treatment platelet reactivity (HPR) in patients with ischemic stroke. However, studies on the relationship between prediabetes and the occurrence of HPR remain scarce. This study is aimed at clarifying the association between prediabetes and HPR among patients with recent ischemic stroke or transient ischemic stroke (TIA).

Methods

Patients with ischemic stroke or TIA within 90 days after onset were recruited consecutively. All patients were divided into three groups: DM, prediabetes, and normal glucose tolerance according to fasting glucose, HbA1c, or OGTT. Three months later, all patients were performed platelet aggregation inhibition test and screened for high on-treatment platelet reactivity. The effect of prediabetes on HPR was analyzed in a multivariable logistic regression model.

Results

This study recruited 237 patients with ischemic stroke or TIA, including 57 cases with prediabetes, 108 with DM, and 72 with normal glucose tolerance. Aspirin and/or clopidogrel resistance was discovered in 28 cases among prediabetes group, which was significantly more frequent than normal glucose tolerance group(49.1% versus 33.3%, P = 0.046). After adjusting for confounding factors, prediabetes was found as an independent risk factor for high on-treatment platelet reactivity (HPR) among patients with recent ischemic stroke or TIA (odds ratio 2.92; 95% CI, 1.29 to 6.63, P = 0.01).

Conclusions

Prediabetes was an independent risk factor for high on-treatment platelet reactivity in patients with recent ischemic cerebrovascular disease. Patients with prediabetes should be highlighted for the efficacy test of antiplatelet drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The protocol and the statistical analysis plans are available on reasonable request. Deidentified participant data are not available for legal and ethical reasons.

References

  1. Cai G, Zhou W, Lu Y, Chen P, Lu Z, Fu Y (2016) Aspirin resistance and other aspirin-related concerns. Neurol Sci 37(2):181–189. https://doi.org/10.1007/s10072-015-2412-x

    Article  PubMed  Google Scholar 

  2. Coignion C, Poli M, Sagnier S, Freyburger G, Renou P, Debruxelles S, Rouanet F, Sibon I (2015) Interest of antiplatelet drug testing after an acute ischemic stroke. Eur Neurol 74(3–4):135–139. https://doi.org/10.1159/000438722

    Article  CAS  PubMed  Google Scholar 

  3. Yi X, Zhou Q, Lin J, Chi L (2013a) Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events. International Journal of Stroke: official Journal of the International Stroke Society 8:535–539. https://doi.org/10.1111/j.1747-4949.2012.00929.x

    Article  Google Scholar 

  4. Floyd CN, Ferro A (2015) Antiplatelet drug resistance: molecular insights and clinical implications. Prostaglandins Other Lipid Mediat 120:21–27. https://doi.org/10.1016/j.prostaglandins.2015.03.011

    Article  CAS  PubMed  Google Scholar 

  5. Laurent B, Udaya ST, Rossella M, Ruediger B, Dominick JA, Richard B, Deepak LB, Marco C, Jean PC, Thomas C, Christian G, Gilles M, Lisa KJ, Dean K, Dirk S, Dietmar T, Jochem WVW, Franck P, Matthew JP, Ron W, Paul AG (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919–933. https://doi.org/10.1016/j.jacc.2010.04.047

    Article  CAS  Google Scholar 

  6. Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S (2017) High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci 376:112–116. https://doi.org/10.1016/j.jns.2017.03.010

    Article  CAS  PubMed  Google Scholar 

  7. Kuliczkowski W, Gasior M, Pres D, Kaczmarski J, Laszowska A, Szewczyk M, Hawranek M, Tajstra M, Zeglen S, Polonski L, Serebruany VL (2015) Aspirin ‘resistance’: impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction. Cardiology 131(1):41–50. https://doi.org/10.1159/000371793

    Article  CAS  PubMed  Google Scholar 

  8. Yi XY, Wang C, Liu P, Fu C, Lin J, Chen YM (2016) Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol 263(8):1612–1619. https://doi.org/10.1007/s00415-016-8181-5

    Article  CAS  PubMed  Google Scholar 

  9. Jia Q, Liu GF, Zheng HG, Zhao XQ, Wang CX, Wang YL, Liu LP, Wang YJ, Gluc ISA (2014) Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke data from abnormal glucose regulation in patients with acute stroke across China. Stroke 45(5):1498–1500. https://doi.org/10.1161/Strokeaha.113.002977

    Article  PubMed  Google Scholar 

  10. Jia Q, Zhao XQ, Wang CX, Wang YL, Yan Y, Li H, Zhong LY, Liu LP, Zheng HG, Zhou Y, Wang YJ (2011) Diabetes and poor outcomes within 6 months after acute ischemic stroke the China National Stroke Registry. Stroke 42(10):2758–2762. https://doi.org/10.1161/Strokeaha.111.621649

    Article  PubMed  Google Scholar 

  11. Jing J, Pan YS, Zhao XQ, Zheng HG, Jia Q, Mi DH, Chen WQ, Li H, Liu LP, Wang CX, He Y, Wang D, Wang YL, Wang YJ, I. ACROSS-China (2017) Insulin resistance and prognosis of nondiabetic patients with ischemic stroke the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China). Stroke 48(4):887–893. https://doi.org/10.1161/Strokeaha.116.015613

    Article  CAS  PubMed  Google Scholar 

  12. Pan Y, Chen W, Xu Y, Yi X, Han Y, Yang Q, Li X, Huang L, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y, Wang Y (2017a) Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation 135(1):21–33. https://doi.org/10.1161/CIRCULATIONAHA.116.024913

    Article  CAS  PubMed  Google Scholar 

  13. Pan YS, Jing J, Chen WQ, Zheng HG, Jia Q, Mi DH, Li H, Zhao XQ, Liu LP, Wang CX, Gaisano HY, He Y, Wang YL, Wang YJ (2017b) Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic stroke. J Am Heart Assoc 6(1):ARTN e004990. https://doi.org/10.1161/JAHA.116.004990

    Article  Google Scholar 

  14. Frontroth JP (2013) Light transmission aggregometry. Methods Mol Biol 992:227–240. https://doi.org/10.1007/978-1-62703-339-8_17

    Article  CAS  PubMed  Google Scholar 

  15. Hvas AM, Favaloro EJ (2017) Platelet function analyzed by light transmission aggregometry. Methods Mol Biol 1646:321–331. https://doi.org/10.1007/978-1-4939-7196-1_25

    Article  CAS  PubMed  Google Scholar 

  16. Liu L, Gao YH, Cao J, Zhang HX, Fan L, Hu GL (2016) High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome. Journal of geriatric cardiology: JGC 13:531–536. https://doi.org/10.11909/j.issn.1671-5411.2016.06.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bobescu E, Covaciu A, Rus H, Rogozea LM, Badea M, Marceanu LG (2020) Low response to clopidogrel in coronary artery disease. Am J Ther 27(2):e133–e141. https://doi.org/10.1097/MJT.0000000000001099

    Article  PubMed  Google Scholar 

  18. Sharma RK, Voelker DJ, Sharma R (2012) Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag 8:65–75. https://doi.org/10.2147/VHRM.S28090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y, C. investigators (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70–78. https://doi.org/10.1001/jama.2016.8662

    Article  CAS  PubMed  Google Scholar 

  20. Lundstrom A, Laska AC, Von Arbin M, Jorneskog G, Wallen H (2014) Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. Platelets 25(2):102–110. https://doi.org/10.3109/09537104.2013.777951

    Article  CAS  PubMed  Google Scholar 

  21. Masafumi U, Kosuke F, Hiroyuki Y, Tomoyuki I, Tatsuya S, Kenji Y, Shinichiro I, Kazuhiro K, Yoshitaka I, Dominick JA, Shunichi M (2015) Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease. J Thromb Thrombolysis 40(2):174–181. https://doi.org/10.1007/s11239-015-1177-7

    Article  CAS  Google Scholar 

  22. Ferreira IA, Mocking AIM, Feijge MAH, Gorter G, van Haeften TW, Heemskerk JWM, Akkerman JWN (2006) Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 26(2):417–422. https://doi.org/10.1161/01.ATV.0000199519.37089.a0

    Article  CAS  PubMed  Google Scholar 

  23. Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011:742719. https://doi.org/10.1155/2011/742719

    Article  PubMed  PubMed Central  Google Scholar 

  24. Le Guyader A, Pacheco G, Seaver N, Davis-Gorman G, Copeland J, McDonagh PF (2009) Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia. J Diabetes Complicat 23(1):65–70. https://doi.org/10.1016/j.jdiacomp.2007.06.003

    Article  Google Scholar 

  25. Russo I, Viretto M, Barale C, Mattiello L, Doronzo G, Pagliarino A, Cavalot F, Trovati M, Anfossi G (2012) High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets. Diabetes 61(11):2913–2921. https://doi.org/10.2337/db12-0040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Stroke 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 20(10): 1407–1431. https://doi.org/10.1161/01.str.20.10.1407

  27. Al-Jabi SW (2017) Global trends in aspirin resistance-related research from 1990 to 2015: a bibliometric analysis. Basic Clin Pharmacol Toxicol 121(6):512–519. https://doi.org/10.1111/bcpt.12840

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded by National Key Research and Development Program of the Ministry of Science and Technology of The People’s Republic of China (2018YFC1312303, 2016YFC1301604, 2018YFC1705003, 2018YFC2002302).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Weili Jia and Qian Jia. The first draft of the manuscript was written by Weili Jia, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Qian Jia.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest pertaining to this paper.

Ethics approval

This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Ethics Committee at Beijing Tiantan Hospital approved this study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jia, W., Jia, Q., Zhang, Y. et al. Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA. Neurol Sci 42, 2829–2835 (2021). https://doi.org/10.1007/s10072-020-04881-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04881-w

Keywords

Navigation